Rimonabant

Rimonabant is a weight loss product that was originally developed to be an aid for those trying to quit smoking. It is a prescription drug. It was sold in Europe under the name Acomplia and has helped promote weight loss in the severely obese. Rimonabant is a product that has been produced by the same makers of the successful prescription products Ambien (a sleep aid) and Allegra (an anti-allergen).

The Food and Drug Administration (FDA) of the United States has never approved this product for sale in the U.S. but the manufacturers of this product assure us that there is a patent pending. Patents are not the same as FDA approval, just for the record.  Many of the countries where this product was originally approved for sale have since banned it citing the potential costs of Rimonabant outweigh the benefits.

Sanofi-Aventis has since suspended the making of Rimonabant, but they held out for an extended period of time, and some have accused them of actually holding back negative study results, including severe depression in many cases in one study and at least one suicide. Previously named side effects included frequent and severe cases of depression, development of neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease, dependence, impairment of short term memory, amongst other issues.

This product is not only potentially harmful; it is a little bit scary. Most weight loss supplement come with their fair share of possible risks but this list is staggering and markedly more detrimental to your health especially your mental faculties. This is not a product that should be considered further even if you do manage to find it somewhere. There are much safer products available that will help you slim down without increasing your risk of depression or Alzheimer’s. We do not recommend Rimonabant under any circumstances.